Next Article in Journal
Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract
Previous Article in Journal
Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-Analysis
Article

A DNA Vaccine Encoding Plasmodium falciparum PfRH5 in Cationic Liposomes for Dermal Tattooing Immunization

1
Departamento de Parasitologia, Instituto de Ciências Biomédicas II, Universidade de São Paulo, São Paulo 05508-000, Brazil
2
Department of Molecular Physiology, Institute of Animal Physiology, Westfälische Wilhelms University of Münster, 48149 Münster, Germany
*
Author to whom correspondence should be addressed.
Vaccines 2020, 8(4), 619; https://doi.org/10.3390/vaccines8040619
Received: 24 August 2020 / Revised: 12 October 2020 / Accepted: 14 October 2020 / Published: 20 October 2020
Vaccines are the primary means of controlling and preventing pandemics and outbreaks of pathogens such as bacteria, viruses, and parasites. However, a major drawback of naked DNA-based vaccines is their low immunogenicity and the amount of plasmid DNA necessary to elicit a response. Nano-sized liposomes can overcome this limitation, enhancing both nucleic acid stability and targeting to cells after administration. We tested two different DNA vaccines in cationic liposomes to improve the immunogenic properties. For this, we cloned the coding sequences of the Plasmodium falciparum reticulocyte binding protein homologue 5 (PfRH5) either alone or fused with small the small hepatitis virus (HBV) envelope antigen (HBsAg) encoding sequences, potentially resulting in HBsAg particles displaying PfRH5 on their outside. Instead of invasive intraperitoneal or intramuscular immunization, we employed intradermal immunization by tattooing nano-encapsulated DNA. Mice were immunized with 10 μg encapsulated DNA encoding PfRH5 alone or in fusion with HBsAg and this elicited antibodies against schizont extracts (titer of 104). Importantly, only IgG from animals immunized with PfRH5-HBs demonstrated sustained IgG-mediated inhibition in in vitro growth assays showing 58% and 39% blocking activity after 24 and 48 h, respectively. Intradermal tattoo-vaccination of encapsulated PfRH5-HBsAg coding plasmid DNA is effective and superior compared with an unfused PfRH5-DNA vaccine, suggesting that the HBsAg fusion may be advantageous with other vaccine antigens. View Full-Text
Keywords: nucleic acid vaccines; cationic liposomes; in vivo delivery; intradermal immunization; tattooing nucleic acid vaccines; cationic liposomes; in vivo delivery; intradermal immunization; tattooing
Show Figures

Graphical abstract

MDPI and ACS Style

Fotoran, W.L.; Kleiber, N.; Glitz, C.; Wunderlich, G. A DNA Vaccine Encoding Plasmodium falciparum PfRH5 in Cationic Liposomes for Dermal Tattooing Immunization. Vaccines 2020, 8, 619. https://doi.org/10.3390/vaccines8040619

AMA Style

Fotoran WL, Kleiber N, Glitz C, Wunderlich G. A DNA Vaccine Encoding Plasmodium falciparum PfRH5 in Cationic Liposomes for Dermal Tattooing Immunization. Vaccines. 2020; 8(4):619. https://doi.org/10.3390/vaccines8040619

Chicago/Turabian Style

Fotoran, Wesley L., Nicole Kleiber, Christiane Glitz, and Gerhard Wunderlich. 2020. "A DNA Vaccine Encoding Plasmodium falciparum PfRH5 in Cationic Liposomes for Dermal Tattooing Immunization" Vaccines 8, no. 4: 619. https://doi.org/10.3390/vaccines8040619

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop